Effects of Lumber Sustained Natural Apophyseal Glides on Lower Cross Syndrome
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Nov 26, 2024
Trial Information
Current as of July 16, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a treatment technique called sustained natural apophyseal glides (SNAGs) to help people with lower cross syndrome, a condition that often causes lower back pain and poor posture. SNAGs are gentle movements aimed at improving the way the spine moves and reducing discomfort. The research focuses on how these techniques can help correct issues like tight hip muscles and weak abdominal and glute muscles, which can lead to problems in the lower back over time.
To participate in the trial, individuals must be between 30 and 50 years old and experience low back pain related to lower cross syndrome. Participants should have specific muscle imbalances and posture issues, such as tight hip flexors and an exaggerated curve in the lower back. If eligible, participants can expect a non-invasive approach to managing their condition, which may improve their overall movement and comfort. It's important to note that individuals with certain back problems, recent surgeries, or specific health conditions may not qualify for the study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 30 to 50 years.
- • Both genders
- • Patient came with the complain of low back pain.
- • Participants had to present with pain and hypomobility due to lower cross syndrome
- • Participants had to meet the criteria for lower cross syndrome indicating tight hip flexors and erector spinae along with weak abdominals and glutei muscles
- • Participants with hyperlordotic curve due to lower cross syndrome
- • Participants presenting with anterior pelvic tilting greater than angle \>7-10 degrees
- • Willing to provide informed consent to participate in study
- • Exclusion Criteria:Participants contraindicated to spinal manipulation
- • Musculoskeletal pathologies affecting the lower back, pelvis, hips, or lower extremities (e.g., herniated disc, lumbar radiculopathy, lumbar stenosis, hip labral tear).
- • Participants who had undergone any lumber or pelvic surgery, as it will affect sacroiliac joint mechanics.
- • Generalized inflammatory or infective connective tissue disorder
- • Pregnancy
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kotli, Azad Kashmir, Pakistan
Patients applied
Trial Officials
Asmar Fatima, MS OMPT
Principal Investigator
Riphah International University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported